AI assistant
Sending…
OMNICELL, INC. — Director's Dealing 2016
Jul 1, 2016
31980_dirs_2016-07-01_02c0ad00-4672-4a1e-b917-5a13e919fa9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2016-07-01
Reporting Person: Seim Robin Gene (EVP, Global A & M Adherence)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-01 | Common Stock | M | 3645 | $0.00 | Acquired | 59065 | Direct |
| 2016-07-01 | Common Stock | S | 3645 | $35.00 | Disposed | 55420 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-01 | NQ Stock Options (right to buy) | $25.08 | M | 3645 | Acquired | 2024-02-04 | Common Stock (3645) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 55420 | Direct |
Footnotes
F1: The Sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. These shares were sold at $35.00 exactly. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
More from OMNICELL, INC.
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Regulatory Filings
2026
Feb 5